Stock News The Mugglehead sin stock roundup More millionaires are made during recessions than at any other time, and the difference is time, due diligence and sin stocks. Joseph MortonAugust 15, 2022
Cannabis Tetra Bio-Pharma enters Australia via new subsidiary acquisition Canadian company set to focus clinical trials down under, announces regulatory update Rowan DunneJune 6, 2022
Cannabis Khiron reaches new medical revenue records in Q1 Company growth within Colombia and Europe responsible for financial success this quarter Rowan DunneJune 1, 2022
Business Canopy Growth reports $112M in Q4 revenue, down 25% year-over-year Cannabis revenue of $66 million during the fourth quarter represented a decline of 35 per cent Ryan GarnerMay 31, 2022
Canada Kiaro unveils personalized membership service MyHempisphere program to be tailored to each customer Rowan DunneMay 30, 2022
Cannabis Legal cannabis market projected to have steady growth into 2030: report Industry is set to expand by approximately US$155 billion between 2020-2030 Rowan DunneMay 30, 2022
Business Nova Cannabis sees Q1 sales increase to $49.8M Nova’s sales growth resulted from new retail stores, transition to Value Buds low-cost model Ryan GarnerMay 10, 2022
Analysis Reddit traders send pot stocks to the moon — and back Cannabis stock spikes fueled by Reddit traders this week have little to do with fundamentals, says TradingView GM Pierce Crosby Jared GnamFebruary 12, 2021
Analysis Canopy shares surge on 2022 profit prediction Despite reporting a $829M Q3 loss, shares are up as the Canadian weed giant predicts US legalization will spur profits Jared GnamFebruary 9, 2021
CBD Martha Stewart and Canopy Growth release CBD dog treats — but are they safe? While initial research suggests CBD is well-tolerated in pups, even Canopy recommends consulting your vet before starting any cannabis treatment Ashley KeenanJanuary 31, 2021